MedPath

辽宁海神联盛制药有限公司

Ownership
-
Established
2001-02-27
Employees
-
Market Cap
-
Website
www.yaopinnet.com/c/c15933.htm

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Levofloxacin Lactate and Sodium Cholride Injection

Product Name
乳酸左氧氟沙星氯化钠注射液
Approval Number
国药准字H20064384
Approval Date
Feb 24, 2021
NMPA

Levofloxacin Lactate and Sodium Cholride Injection

Product Name
乳酸左氧氟沙星氯化钠注射液
Approval Number
国药准字H20064385
Approval Date
Feb 24, 2021
NMPA

Hydroxyethyl Starch 130/0.4

Product Name
羟乙基淀粉130/0.4
Approval Number
国药准字H20103482
Approval Date
Aug 10, 2020
NMPA

Azithromycin and Glucose Injection

Product Name
利力凯
Approval Number
国药准字H20041884
Approval Date
Jun 19, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20084568
Approval Date
Jun 19, 2020
NMPA

Puerarin and Sodium Chloride Injection

Product Name
唯新
Approval Number
国药准字H20051160
Approval Date
Jun 19, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20083483
Approval Date
Jun 19, 2020
NMPA

Nicardipine Hydrochloride and Glucose Injection

Product Name
丹颐
Approval Number
国药准字H20000485
Approval Date
Jun 19, 2020
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H21021754
Approval Date
Jun 19, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H21020754
Approval Date
Jun 19, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.